CONFERENCE PROCEEDING
Transferring model of nicotine dependence treatment in University of Virginia Cancer Center to National Research Institute of Oncology
More details
Hide details
1
Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
2
UVA Cancer Center, University of Virginia, Charlottesville, United States
Publication date: 2022-07-05
Tob. Prev. Cessation 2022;8(Supplement):A34
ABSTRACT
Background:
The health benefits of quitting smoking after cancer diagnosis
are indisputable. Apart from disease site and stage, abstinence
from smoking is considered the strongest predictor of survival in
cancer patients who have ever smoked. The evidence is strong
enough to incorporate tobacco dependence treatment into routine
cancer care, but in Central and Eastern Europe only few cancer
care institutions utilize systematic and consistent mechanism to
foster cessation among patients with cancer. In contrast to CEE
countries, a good example of standard smoking cessation service
for cancer patients could be observed at the cancer center in
The University of Virginia (UVA). A tobacco treatment program
to help meet the needs for cancer patients includes medication
management with the 7 FDA approved medications and individual
counseling. Medications may be combined in many different ways
to reduce physical withdrawals and improve rates of success. The
structure of treatment is a standard developed to offer a balanced
approach to meet the needs of the patient while managing their
physical and mental quit journey.
Objective:
The aim is to assess a possible transfer and adaptation of solutions
developed at the cancer center of University of Virginia in the United
States in 2021 in the Polish National Research Institute of Oncology.
Methods:
Analysis of the systematic solutions toward smoking cancer patients implemented in cancer center at University of Virginia.
It includes procedures and materials given to patients and their
families.
Results:
Treatment at the University of Virginia has been integrated into
the electronic health records and workflow of staff. Every patient is
asked about tobacco use and encouraged to think about cessation.
If a patient is interested, they are referred to a Certified Tobacco
Treatment Specialist to discuss an individualized plan to work
towards tobacco cessation. The program has developed a manual
to assist other departments with implementing the program
features in work flow through a standardized approach. Patients
receive multiple sessions for medication management, cognitive
behavioral counselling, and continued motivational interviewing.
Conclusions:
Despite many differences between the American and Polish
populations, the specificity of nicotine addiction is similar among
smokers almost all over the world. Given the importance of
smoking and its impact on cancer treatment outcomes, there is a
strong need to research and implement best practices such as that
of the University of Virginia.